Article Text

Download PDFPDF
Original article
Detection of very early stent healing after primary angioplasty: an optical coherence tomographic observational study of chromium cobaltum and first-generation drug-eluting stents. The DETECTIVE Study
  1. Francesco Prati1,2,
  2. Filippo Stazi1,
  3. Jaime Dutary3,
  4. Alessio La Manna4,
  5. Alessandro Di Giorgio1,4,
  6. Tomasz Pawlosky5,
  7. Nieves Gonzalo3,
  8. Maria Elena Di Salvo4,6,
  9. Fabrizio Imola1,
  10. Corrado Tamburino4,6,
  11. Mario Albertucci2,
  12. Fernando Alfonso3
  1. 1Interventional Cardiology, San Giovanni Hospital, Rome, Italy
  2. 2Centro per la Lotta contro l'Infarto Fondazione Onlus (CPI) Foundation, Rome, Italy
  3. 3Interventional Cardiology, Clinico San Carlos University Hospital, Madrid, Spain
  4. 4Cardiology Department, Ferrarotto Hospital, Catania, Italy
  5. 5Klinika Kardiologii Inwazyinej, Warsaw, Poland
  6. 6ETNA Foundation, Catania, Italy
  1. Correspondence to Dr Francesco Prati, Interventional Cardiology, San Giovanni Hospital, Via dell'Amba Aradam 8, 00184 Rome, Italy; fprati{at}hsangiovanni.roma.it

Abstract

Background Lack of stent coverage appears to be associated with stent thrombosis, a problem of particular concern in patients with ST elevation myocardial infarction (STEMI).

Methods The DETECTIVE European Multicenter Registry was set up to address the early modality of stent healing in the setting of STEMI. The Registry compared, with an early optical coherence tomography (OCT) evaluation performed at 3–7 days, the patterns of coverage and apposition of the first generation of drug-eluting stents (DESs) and cobalt chromium non-drug-eluting stents (CCSs) that were deployed in culprit lesions and in non-culprit segments. The Registry included only patients with a multi-vessel disease to allow, at 3–7 days from the first angioplasty, a deferred OCT examination and a staged intervention in another vessel.

Results 28 stented lesions (15 patients) eventually entered the final OCT assessment. 13 stents were first-generation DESs, while the remaining 15 were CCSs. 18 stents (64%) were deployed at culprit STEMI lesions, and the remaining 10 (36%) were deployed at non-culprit sites. The distribution of clinical and procedural variables in DES and CCS as well as in culprit and non-culprit sites was not different. In total, 27 019 struts were analysed in 28 stents. The percentage of stent uncoverage in the overall analysis was 11.7%, while the percentage of malapposition and that of struts covered with thrombus were 4.8% and 2.2%, respectively. A low percentage of strut uncoverage was found in all the four studied subgroups: DES 12.8%, CCS 10.9%, stents deployed in culprit lesions 13.2% and stents deployed in non-culprit lesions 8.7%.

Conclusions In conclusion, our data show that in patients with STEMI, a very high percentage of stent struts is covered by an early thin rim of tissue within 7 days after stent positioning. The present data bring new insights in the mechanism and timing of strut coverage.

  • Stent
  • optical coherence tomography
  • vessel healing

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.